How Old Is Neil Diamond

How much does Neil Diamond earn from Sweet Caroline?

Neil Diamond is one savvy businessman. In a heartfelt, spontaneous gesture, the singer-songwriter showed up at Fenway Park last week to lead the Boston fans in the eighth-inning singing of “Sweet Caroline.” Sales of the informal Red Sox anthem spiked, and Diamond tweeted Wednesday that he’s donating the week’s royalties to marathon bombing victims.

1. But how much are we talking, really? The song sold 19,000 units in the past week, up from 2,800 the week before, reports AP.
2. A rough number crunch shows that Diamond’s gift will come to about $5,000 — not chopped liver, but no windfall.
3. The music business is notoriously secretive and complicated when it comes to money, but we spoke to some industry sources and it breaks down like this: Songwriters get paid every time a song is played or performed; singers get paid separately, and singer-songwriters earn the most.

It’s just pennies per play, but adds up fast. Diamond has sold 1.75 million copies of “Sweet Caroline” since he wrote it in 1969, which earns him “$300,000 to $500,000 a year, depending on how much licensing there is,” estimates a music executive. That includes commercials, touring, overseas rights, etc.

• And that’s just one of Diamond’s many hit songs.
• Or consider Bill Danoff.
• In the ‘70s, the D.C.
• Songwriter and his ex-wife wrote the John Denver mega-hit “Take Me Home, Country Roads,” then he hit #1 with “Afternoon Delight.” The two songs took on lives of their own: “Afternoon Delight” keeps popping up on TV shows and in movies; “Country Roads” is the theme song for the West Virginia Mountaineers (played at every game) and an international favorite, too.

“My overseas royalties far exceed my American royalties — especially in Germany where everyone sings it at Oktoberfest,” Danoff told us. The two hits, along with his other songs, bring in more than $200,000 a year. And everyone in the music business knows the Dolly Parton story: She wrote “I Will Always Love You” in 1974 and hit #1 on the country charts.

How old is Neil Diamond’s wife Katie?

Has anyone ever recovered from Parkinson’s disease?

While there is no cure for Parkinson’s disease, there are documented cases of improvement and recovery. Recovery in these cases is defined mainly by an elimination of motor symptoms.

Has anyone ever survived Parkinson’s disease?

Stages 4 and 5 – In the advanced stages of Parkinson’s, some treatments may become less effective. However, if they provide even small benefits, it may be worth continuing them. In some cases, doctors may change the delivery of some medications. For example, those with more advanced Parkinson’s may receive an infusion of carbidopa-levodopa rather than an oral dose.

The continual infusion keeps the blood levels of the drugs constant. In these stages, people may undergo surgical procedures, such as deep brain stimulation (DBS), DBS involves implanting electrodes into the brain to emit electrical pulses that help reduce symptoms. Parkinson’s disease is not fatal, as the condition itself does not cause death.

However, some complications that arise from Parkinson’s, including infections and falls, can be fatal. Treatments and lifestyle changes can help people manage their symptoms and reduce their risk of complications. It is worth remembering that due to modern treatments and healthcare services, most people living with Parkinson’s disease now live as long, or almost as long, as those without this condition.

What stage of Parkinson’s is Michael J Fox?

From Our Archives – Michael J. Fox is due to say goodbye to the television program Spin City on the May 24 show. We are therefore rerunning an article we wrote a while back about Mr. Fox and Parkinson disease to put this matter in a medical perspective.

1. Medical Editor, MedicineNet.com The 37-year-old Canadian actor Michael J.
2. Fox has Parkinson disease, a progressive degenerative disease of the part of the brain called the substantia nigra that controls movement.
3. Although Parkinson disease occurs mostly in older people, it sometimes does strike people in their forties or, as with Mr.

Fox, even younger people. Mr. Fox was first diagnosed when he noticed a “twitch” in his left little finger while he was working on the set of the 1991 film Doc Hollywood, he told People magazine. Parkinson disease has several classic signs and symptoms including tremors, stiffness of the limbs, a mask-like face, gait disturbance (difficulty walking ), depression and, late in the disease, dementia,

The tremor is characteristically a resting tremor that especially involves the hands and fingers. It is described as a “pill rolling” tremor, a name that harks back to the similarity between the tremor’s movement and that required to “roll a pill” in pharmacies past. In the early stages of Parkinson disease, the tremor stops when the person does something active, such as walking.

Mr. Fox said that he paced during an interview to quell his tremor. After the diagnosis in 1991, Fox’s disease progressed over the next few years affecting his entire left side with tremors and stiffness. Michael J. Fox said he is in the “late mild” stage of the disease.

1. For clinical purposes, Parkinson disease is arbitrarily divided into mild, medium, and severe stages.
2. Stiffness of the limbs and difficulty starting movements are characteristic.
3. In the early stages of the disease, this may show up as trouble running, etc.
4. As the disease worsens, the patient may have a difficult time initiating activities such as walking or dressing.

Mr. Fox said that sometimes he is so stiff he cannot pick up and operate his TV remote control. Along with a limited capacity to moving the arms and legs, a patient with Parkinson disease also experiences a decreased ability to move the muscles of the face.

• As a result, the facial expression tends to be unchanging and is said to be “mask-like.” Another feature of Parkinson disease is difficulty stopping an action once it has been started.
• For instance, patients may have trouble stopping once they do start walking.
• Affected individuals may walk faster and faster until they fall or hit something in their path.

Up to 50% of patients develop depression and 20% suffer memory loss. Additionally, some people with Parkinson disease may have hallucinations, seeing and hearing things that are not real. While there are no medications that can stop Parkinson disease from progressing, many good medical treatments are available for its symptoms.

Fox takes the drug Sinemet ( levodopa-carbidopa ). It controls some of the milder symptoms, including, “the constant rigidity of his hips, tremors in one or both hands, and a ‘tapping’ feeling in his feet,” Mr. Fox reportedly has also had brain surgery (on the thalamus) to try to relieve his tremors.

Among Mr. Fox’s reasons for going public about his condition is his desire to raise public awareness of Parkinson disease and funds for it. For more on this disorder, please see the Diseases and Treatments Forum on Parkinson Disease.

How old was Michael J Fox when he got Parkinson’s?

Updated on: May 13, 2023 / 10:28 AM / CBS News Michael J. Fox on Parkinson’s, and maintaining optimism Michael J. Fox on Parkinson’s, and maintaining optimism 08:03 Michael J. Fox has suffered from a number of injuries as a result of his Parkinson’s disease, which he was diagnosed with in 1991 at age 29, the actor revealed in an interview with Variety this week. The 61-year-old “Back to the Future” star opened up about his battle with the disease, explaining the injuries he has gotten from losing his balance. The neurological disorder causes unintended stiffness, shakiness and difficulty with coordination, and worsens over time, according to the National Institutes of Health, “I broke this shoulder — had it replaced. I broke this elbow. I broke this hand. I had an infection that almost cost me this finger. I broke my face. I broke this humerus,” Fox told Variety.

Michael J. Fox on Parkinson’s and how he finds “optimism is sustainable”

Fox said it has been difficult to manage his illness over the years, during which he has suffered through other personal losses and mental health struggles, in addition to already managing his Parkinson’s symptoms. “I have aides around me quite a bit of the time in case I fall, and that lack of privacy is hard to deal with,” he said in the interview.

“I lost family members, I lost my dog, I lost freedom, I lost health. I hesitate to use the term ‘depression,’ because I’m not qualified to diagnose myself, but all the signs were there.” While it hasn’t been easy, the “Family Ties” star said he has found comfort in the support of his family, who have been helping him to get through his health issues.

“I just enjoy the little math problems of existence,” the actor said. “I love waking up and figuring that stuff out and at the same time being with my family.” And, he’s come to a point where he accepts the impacts the debilitating disease may have on his body.

“My problem is I fall down. I trip over things and fall down and break things. And that’s part of having this,” Fox said. “But I hope that, and I feel that, I won’t break as many bones tomorrow. So that’s being optimistic.” Fox also spoke about his experiences in a recent interview with CBS “Sunday Morning,” in which he reflected on how long Parkinson’s has been part of his life.

“It’s been 30+ years; not many of us that have had this disease for 30 years,” he said. “It sucks having Parkinson’s.” Since going public about his illness in 1998, Fox has worked hard to raise money for Parkinson’s, a disease he learned was underfunded for research and treatment development.

1. The nonprofit Michael J.
2. Fox Foundation, which was founded in 2000, has raised more than $1.5 billion for Parkinson’s research, according to its website.
3. Parkinson’s disease affects about 500,000 Americans, according to the National Institutes of Health, but some experts estimate that as many as one million Americans may have the disease, as it often goes undiagnosed.

Fox retired from acting in 2020 due to struggles with learning lines and acting as a result of the disease, but he is soon appearing in a new documentary about his life, “Still: A Michael J. Fox Movie,” which details his successful career, his journey with sobriety, his battle with Parkinson’s, and his determined spirit to continue living on his own terms despite the disease’s immobilizing symptoms.

In: Hollywood Parkinsons Disease Michael J. Fox

Simrin Singh Simrin Singh is a social media producer and trending content writer for CBS News. Thanks for reading CBS NEWS. Create your free account or log in for more features. Please enter email address to continue Please enter valid email address to continue

Can you live a happy life with Parkinson’s?

Living with Parkinson’s can affect the way you carry out a broad range of everyday activities, from working and driving, to simply eating and brushing your teeth. But by making some small changes in your lifestyle and also in your approach to activities, you can maintain independence and continue many of your usual routines.

What is the lifetime chance of Parkinson’s?

DISCUSSION – In this large prospective cohort study among male physicians, the average annual incidence of PD was 121 cases/100,000 person-years. The age-specific incidence increased steeply through age 89 years and then declined in the 10th decade of life.

• Unadjusted cumulative incidence substantially overestimated the true risk of PD in those aged 80 years and older.
• The lifetime risk curve for PD reached a plateau by age 90 years.
• The cumulative incidence and lifetime risks of PD decreased substantially with increasing smoking exposure.
• Our study has several strengths, including its large number of participants and outcome events, prospective design, and well-defined population with a long follow-up.

We were able to adjust cumulative incidence for competing risks using mortality information from the same population and could perform stratified analyses by smoking status. A number of limitations should be considered in the interpretation of our results.

First, our diagnosis of PD was based on self-reports. However, prior work has shown the self-reported diagnosis of PD to be highly valid in a population of health professionals.14 Direct validation of more than 10% of self-reported PD diagnoses using available medical records revealed an accuracy of 90%, which is similar to that found in validation studies of self-reported hypercholesterolemia and hypertension in the PHS.15 However, despite this good validation, misclassification of PD remains possible.

A number of factors limit the generalizability of our results to other populations. Our cohort was composed of white men of the same educational level and profession who were motivated to modify their risks for disease. They also may have higher rates of disease diagnosis than nonphysicians because of easier access to medical care.

1. However, our incidence estimates for PD were similar to that of a population-based study with direct ascertainment.16 We were unable to estimate the incidence and risk of PD in women.
2. Prior estimates of PD incidence have varied widely depending on nationality, sex, population age distribution, and case ascertainment methods.

General populations have an average estimate of 13 cases/100,000 (range 1.5–26), 17 whereas populations aged 65 years and older have an average of 180 cases/100,000 (range 89–332).16,18–22 We recalculated the incidence rates of studies that evaluated most or all population members using accepted diagnostic criteria and reported age-specific incidence in older white men ( table 4 ).

• The rate obtained in our cohort (224 cases/100,000 person-years) was similar to that of the Rotterdam Study (261 cases/100,000 person-years), 16 a primarily white population-based cohort in which the diagnosis of PD was obtained by direct screening followed by a detailed clinical workup.
• Thirty-nine percent of PD cases were newly diagnosed by study physicians, demonstrating the substantial number of patients with PD who are missed when case finding is based on medical records alone.

Despite the fact that our participants are physicians with easy access to medical care, our rate was lower than that of two door-to-door studies of elders in Italy and Spain, in which PD was directly ascertained.18,19 Finally, our rate was higher than that in three US-based studies in which no population screening was performed and cases were found through health care providers or medical records systems.6,21,22 Table 4 Comparison of the Physicians’ Health Study with studies using widely accepted diagnostic criteria that report crude annual incidence of Parkinson disease in men In our cohort, PD incidence increases through age 89 years and then declines in the 10th decade of life. In the majority of studies reporting age-specific incidence in white men, incidence increases through the oldest age group, 16,18,19,21–23 as it does in our study when those aged 85 years and older are combined.

However, a number of well-conducted studies show a decline in PD incidence in men after age 75 or 79 years.6,23–25 Similar results have been found for AD in a cohort characterized by exceptional longevity in which the incidence of AD in men began to decline in their early 90s.26 It is unclear whether the observed decline represents a true decrease in the risk of PD or is simply due to underdiagnosis.

Older patients may become lost to follow-up, particularly in studies with less-intensive cohort surveillance.23 Because parkinsonian signs as well as comorbidities increase markedly with age, 27 the decline of PD in the oldest old may also reflect the difficulty of distinguishing idiopathic PD from other causes of parkinsonism.20 In the Rochester Epidemiology Project, the incidence of PD declined in men after age 79 years when strict diagnostic criteria were used, but continued to increase through age 99 years when broad criteria were used.28 When we included PD patients with concurrent dementia, the incidence rate increased slightly but still declined after age 89 years (data not shown).

Our study provides evidence that PD incidence increases at least to age 90 years, thus shifting to the right the age where we can be confident that incidence is still increasing. Cumulative incidence is often used to provide a measure of long-term disease risk. However, it overestimates the incidence when the disease has a prevalence of 10% or greater, or the competing risk of mortality is high.29 The lifetime risk method adjusts the incidence rate of a disease by the all-cause mortality rate in the population.

It thus provides the actual risk of developing the disease before dying of some other cause, assuming one has survived free of that disease to a specified age. Lifetime risk estimates are helpful as an absolute measure of long-term individual risk and are easily understood by the lay public.

They are increasingly being used by researchers and policy makers to predict population risks 30 and develop clinical practice guidelines.31,32 Our study illustrates the importance of adjusting for the competing risk of death when estimating the incidence of a disease in an older population. The cumulative incidence of PD from ages 45 to 100 years was 9.9% (1 in 10), but mortality-adjusted lifetime risk for the same period was 6.7% (1 in 15).

Our estimate of lifetime cumulative incidence at age 40 years was remarkably similar to that of the Rochester Epidemiology Project (10.9%), but our estimates of lifetime risk were higher. This likely reflects the increased longevity of our cohort, which has a life expectancy of 49.3 additional years at age 40 years, 12 years longer than that of 40-year-old men in the general US population.33 Populations with a longer life expectancy have a longer period at risk; thus, lifetime risk estimates cannot be compared across different populations unless they have similar mortality rates.

Although smoking is known to decrease PD risk, 34 it increases the risk of many other major diseases and of death. The cumulative incidence of PD decreased as the level of smoking exposure increased, suggesting a dose–response relationship between smoking and protection from PD. The lifetime risk of PD followed the same pattern ( figure, D ), and lifetime risk in heavy smokers (2.3%) was substantially less than in never-smokers (7.8%).

The difference in lifetime risk curves between ever- and never-smokers was accounted for by increased mortality from cardiovascular disease, cancer, and pulmonary disease among smokers (data not shown). Because we had relatively few current smokers in the cohort, smoking-associated mortality rates were lower than might be found in a general population.

• In a cohort with a higher smoking exposure, both cumulative incidence and lifetime risks of PD among smokers might be even lower.
• It is worth emphasizing that while smoking may decrease the incidence of PD by some protective factors, it decreases the lifetime risk of PD by substantially increasing the risk of death from smoking-related diseases.

We were unable to address the incidence and lifetime risk of PD in women. Women are known to have a twofold decreased risk of PD compared with men, 20 which seems to persist even to very old ages.18 On the other hand, older women have increased longevity compared with men and are less likely to be smokers.

1. Thus, although incidence in men is higher at all ages, the difference in lifetime risk between men and women likely decreases with age.6 Further studies of lifetime risk in elderly women are needed.
2. Our results illustrate the sensitivity of PD incidence and risk estimates to a number of factors, including the age and longevity of the population, methods of case finding, the strictness of PD criteria, and the prevalence of smoking.

In this population of health-conscious male physicians with exceptional longevity, PD incidence increased sharply to age 90 years, and lifetime risk was as high as 1 in 15 at age 40 years. As life expectancy increases worldwide, similar lifetime risks can be expected in general populations.

Has anyone ever recovered from Parkinson’s disease?

While there is no cure for Parkinson’s disease, there are documented cases of improvement and recovery. Recovery in these cases is defined mainly by an elimination of motor symptoms.

Is there a life expectancy for Parkinson’s?

Stages 4 and 5 – In the advanced stages of Parkinson’s, some treatments may become less effective. However, if they provide even small benefits, it may be worth continuing them. In some cases, doctors may change the delivery of some medications. For example, those with more advanced Parkinson’s may receive an infusion of carbidopa-levodopa rather than an oral dose.

• The continual infusion keeps the blood levels of the drugs constant.
• In these stages, people may undergo surgical procedures, such as deep brain stimulation (DBS),
• DBS involves implanting electrodes into the brain to emit electrical pulses that help reduce symptoms.
• Parkinson’s disease is not fatal, as the condition itself does not cause death.

However, some complications that arise from Parkinson’s, including infections and falls, can be fatal. Treatments and lifestyle changes can help people manage their symptoms and reduce their risk of complications. It is worth remembering that due to modern treatments and healthcare services, most people living with Parkinson’s disease now live as long, or almost as long, as those without this condition.